Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · April 10, 2014

Biologics Cause Few Adverse Events in Psoriasis

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the European Academy of Dermatology and Venereology: JEADV
Risk of Adverse Events in Psoriasis Patients Receiving Classic Systemic Drugs and Biologics in a 5-Year Observational Study of Clinical Practice: 2008-2013 Results of the Biobadaderm Registry
J Eur Acad Dermatol Venereol 2014 Mar 31;[EPub Ahead of Print], G Carretero, C Ferrandiz, E Dauden, F Vanaclocha Sebastián, FJ Gómez-García, E Herrera-Ceballos, P De la Cueva-Dobao, I Belinchón, JL Sánchez-Carazo, M Alsina-Gibert, JL López-Estebaranz, M Ferrán, R Torrado, JM Carrascosa, C Carazo, R Rivera, R Jiménez-Puya, I García-Doval

Further Reading